There will be space to talk about the latest innovations in gene therapy and genomic editing for metabolic, ocular, and neurological diseases as well as new strategies in precision medicine, with a focus on mitochondrial biology and rare disease research.
Roundtables organized during the meeting will explore the interactions between science and the pharmaceutical industry, addressing biomedical research challenges and strategies.
There will be presentations regarding innovative strategies for treating rare diseases, including dystrophies, retinal dysfunction, and metabolic syndromes and discussions on advanced drug discovery techniques and innovative pharmacological approaches.
The scientific program of the Convention will also address topics very close to Anemocyte such as for example new RNA-based therapies, genomic editing, and drug delivery for genetic and neurodegenerative diseases.
Anemocyte will be present at the event with a booth.
We look forward to meeting you!
